AUROPHARMA Intraday Analysis...
75% Offer Free Offer!!!!! Save Rs 9000/- (75% off) & Get Rs 3000/- Trading fee Bonus on Real Time Intraday Charts Register Now.

AUROPHARMA Share Price

Open 774.00 Change Price %
High 779.00 1 Day -3.40 -0.45
Low 750.00 1 Week 39.20 5.49
Close 753.00 1 Month -6.90 -0.91
Volume 2952953 1 Year -64.55 -7.90
52 Week High 1535.00
52 Week Low 645.45
AUROPHARMA Important Levels
Resistance 2 779.88
Resistance 1 768.81
Pivot 760.67
Support 1 737.20
Support 2 726.12
AUROPHARMA CURRENT MONTH FUTURE
Close 757.05
Contracts Traded 9981
Open Intrest 12672000
Change In O.I 25500
Lot Size 500
AUROPHARMA CURRENT MONTH OPTION
Most Active Call 800
Most Active put 700
Highest O.I Buildup Call 800
Highest O.I Buildup Put 700
Expiry Date 24-Sep-2015
AUROPHARMA ALL MONTHS OPTIONS
For All AUROPHARMA Options Click Here
NSE INDIA Most Active Stocks
NIFTY 7971.30 -0.38%
JINDALSTEL 67.55 -0.07%
UNITECH 6.05 0.00%
ADANIPORTS 355.45 -1.99%
IBULHSGFIN 755.05 -2.84%
SBIN 247.35 -0.64%
JPASSOCIAT 9.65 -1.03%
SUZLON 22.10 0.00%
GLENMARK 1154.80 -1.70%
CNXIT 11605.70 0.15%
More..
NSE INDIA Top Gainers Stocks
VISESHINFO 0.10 100.00%
SRGINFOTEC 0.20 33.33%
KSERASERA 0.20 33.33%
PARASPETRO 0.25 25.00%
RASOYPR 0.25 25.00%
ALPHAGEO 401.40 20.00%
DSKULKARNI 124.20 19.54%
CREATIVEYE 3.60 16.13%
UNIENTER 42.75 14.77%
MVL 0.40 14.29%
More..
NSE INDIA Top Losers Stocks
SURANAT&P 4.25 -15.00%
SALSTEEL 1.60 -13.51%
ATNINTER 0.35 -12.50%
PARACABLES 2.15 -12.24%
NICCO 0.40 -11.11%
VIMALOIL 68.55 -9.74%
SEZAL 4.30 -9.47%
TRF 200.70 -9.43%
TRF 200.70 -9.43%
TAINWALCHM 40.75 -9.34%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 5
As on 31st Aug 2015 AUROPHARMA Share Price closed @ 753.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1127.79 & Strong Sell for SHORT-TERM with Stoploss of 1051.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for September
1st Target up-side 1206.8
2nd Target up-side 1520.04
3rd Target up-side 1833.28
1st Target down-side 313
2nd Target down-side -0.24
3rd Target down-side -313.48
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 68.32 Sideways
MFI (14) MFI is 54.52 Sideways
CCI (20) CCI is -13.16 Sideways
WILLIAM %R (14) William %R is -42.53 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 658.30
10 Day Avg Volume Traded 16.95 % More then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.